| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10011452 | HBV | ENSG00000117601.15 | protein_coding | SERPINC1 | No | No | 462 | P01008 |
| TVIS10011453 | HBV | ENSG00000117601.15 | protein_coding | SERPINC1 | No | No | 462 | P01008 |
| TVIS10021160 | HBV | ENSG00000117601.15 | protein_coding | SERPINC1 | No | No | 462 | P01008 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SERPINC1 |
|---|---|
| DrugBank ID | DB06271 |
| Drug Name | Sulodexide |
| Target ID | BE0000280 |
| UniProt ID | P01008 |
| Regulation Type | potentiator |
| PubMed IDs | 12818259; 11752352; 9436179 |
| Citations | Cosmi B, Cini M, Legnani C, Pancani C, Calanni F, Coccheri S: Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans. Thromb Res. 2003 Mar 15;109(5-6):333-9.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Harenberg J: Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med Res Rev. 1998 Jan;18(1):1-20. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164746343 |
| ChEMBL | CHEMBL2108086 |
